Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review
Thank you for Subscribing to Healthcare Business Review Weekly Brief
In terms of kidney treatment options, the medical community has advanced significantly.
By
Healthcare Business Review | Tuesday, March 19, 2024
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Renal illness patients are increasingly receiving value-based care or VBC. Given that VBC models can provide higher value and improve patient quality of life, there is a growing emphasis on using them to treat kidney disease
Fremont, CA: In terms of kidney treatment options, the medical community has advanced significantly. With the growing popularity of at-home dialysis and the development of more comprehensive kidney care strategies, new methods are redefining the treatment options available to people with chronic kidney disease (CKD) and developing a type of care that addresses the patient and the illness. The final word is a two-pronged strategy that promises to completely transform the way CKD is identified and managed if implemented sooner rather than later. Payers should keep a close eye on the following advancements.
Value Based Care for Renal Disease
Renal illness patients are increasingly receiving value-based care or VBC. Given that VBC models can provide higher value and improve patient quality of life, there is a growing emphasis on using them to treat kidney disease. Many patients no longer have to deal with the challenges of navigating the complex healthcare system and dialysis on their own after receiving their diagnosis and seeing a nephrologist once.